Differential expression of miRNAs in the serum of patients with high-risk oral lesions

Cancer Medicine

Volumn 1, Issue 2, 2012, Pages 268-274

  MacLellan, Sara Ann ^a   Lawson, James ^a   Baik, Jonathan ^a   Guillaud, Martial ^a   Poh, Catherine Fang Yeu ^a,b   Garnis, Cathie ^a,b  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Biomarkers; Circulating microRNAs; Oral squamous cell carcinoma

Indexed keywords

MICRORNA; MICRORNA 16; MICRORNA 223; MICRORNA 29A; MICRORNA 338 3P; MICRORNA LET 7B; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MOUTH CANCER; NON INVASIVE PROCEDURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; UPREGULATION;

EID: 85038950820     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.17     Document Type: Article

References (26)

1. Warnakulasuriya, S. 2009. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45:309-316.
2. Mitchell, P. S., R. K. Parkin, E. M. Kroh, et al. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Nat. Acad. Sci. U.S.A. 105:10513-10518.
3. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
4. Liu, C. J., S. Y. Kao, H. F. Tu, M. M. Tsai, K. W. Chang, and S. C. Lin. 2010. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis. 16:360-364.
5. Lin, S. C., C. J. Liu, J. A. Lin, W. F. Chiang, P. S. Hung, and K. W. Chang. 2010. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol. 46:204-208.
6. Komatsu, S., D. Ichikawa, H. Takeshita, et al. 2011. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br. J. Cancer 105:104-111.
7. Ohshima, K., K. Inoue, A. Fujiwara, et al. 2010. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One 5:e13247.
8. Kosaka, N., H. Iguchi, Y. Yoshioka, K. Hagiwara, F. Takeshita, and T. Ochiya. 2012. Competitive interactions of cancer cells and normal cells via secretory microRNAs. J. Biol. Chem. 287:1397-1405.
9. Heegaard, N. H., A. J. Schetter, J. A. Welsh, M. Yoneda, E. D. Bowman, and C. C. Harris. 2012. Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int. J. Cancer 130:1378-1386.
10. McDonald, J. S., D. Milosevic, H. V. Reddi, S. K. Grebe, and A. Algeciras-Schimnich. 2011. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin. Chem. 57:833-840.
11. Andreasen, D., J. U. Fog, W. Biggs, et al. 2010. Improved microRNA quantification in total RNA from clinical samples. Methods 50:S6-S9.
12. Mestdagh, P., P. Van Vlierberghe, A. De Weer, et al. 2009. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 10:R64.
13. Chari, R., K. M. Lonergan, L. A. Pikor, et al. 2010. A sequence-based approach to identify reference genes for gene expression analysis. BMC Med. Genomics 3:32.
14. Sing, T., O. Sander, N. Beerenwinkel, and T. Lengauer. 2005. ROCR: visualizing classifier performance in R. Bioinformatics 21:3940-3941.
15. Cervigne, N. K., P. P. Reis, J. Machado, et al. 2009. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum. Mol. Genet. 18:4818-4829.
16. Chen, X., Y. Ba, L. Ma, et al. 2008. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18:997-1006.
17. Cortez, M. A., C. Bueso-Ramos, J. Ferdin, G. Lopez-Berestein, A. K. Sood, and G. A. Calin. 2011. MicroRNAs in body fluids - the mix of hormones and biomarkers. Nature reviews. Clin. Oncol. 8:467-477.
18. Kukreja, R. C., C. Yin, and F. N. Salloum. 2011. MicroRNAs: new players in cardiac injury and protection. Mol. Pharmacol. 80:558-564.
19. Lu, J., G. Getz, E. A. Miska, et al. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834-838.
20. Wong, T. S., X. B. Liu, B. Y. Wong, R. W. Ng, A. P. Yuen, and W. I. Wei. 2008. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin. Cancer Res. 14:2588-2592.
21. Takamizawa, J., H. Konishi, K. Yanagisawa, et al. 2004. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64:3753-3756.
22. Johnson, S. M., H. Grosshans, J. Shingara, et al. 2005. RAS is regulated by the let-7 microRNA family. Cell 120:635-647.
23. Aqeilan, R. I., G. A. Calin, and C. M. Croce. 2010. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ. 17:215-220.
24. Lin, R. J., D. W. Xiao, L. D. Liao, et al. 2012. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. J. Surg. Oncol. 105:175-182.
25. Kozaki, K., I. Imoto, S. Mogi, K. Omura, and J. Inazawa. 2008. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 68:2094-2105.
26. Kikkawa, N., T. Hanazawa, L. Fujimura, et al. 2010. miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC). Br. J. Cancer 103:877-884.